Cefpodoxime Proxetil
Get a Quick Quote Now
Select Packaging
For more information call 
(914) 654-6800or email 
INFO@PARCHEM.COM
(914) 654-6800
INFO@PARCHEM.COM
For more informationemailINFO@PARCHEM.COM
email
INFO@PARCHEM.COM
Product Description
Product
Cefpodoxime Proxetil
CAS
87239-81-4
Formula
C21H27N5O9S2
Synonym
cefpodoxime proxetil, Cefodoxime Proxetil, 87239-81-4, 947692-13-9, (E)-Cefpodoxime Proxetil, anti-Cefpodoxime proxetil, K9VK627SN2, 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, (1RS)-1-(((1-Methylethoxy)carbonyl)oxy)ethyl (6R,7R)-7-(((2E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester, (6R,7R)-, Cefpodoximproxetil, U-76,252;CS-807, UNII-K9VK627SN2, SCHEMBL379709, CHEBI:94455, HMS2093B08, Pharmakon1600-01505637, NSC759161, Cefpodoxime proxetil impurity D [EP], CCG-213498, NCGC00164598-03, SBI-0206821.P001, AB01563099_01, SR-05000001937, Q1052672, SR-05000001937-1, BRD-A87387433-001-01-9, CEFPODOXIME PROXETIL IMPURITY D [EP IMPURITY], L-(-)-Di-1,4-O-benzoyl-L-tartaric acid monohydrate
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Cefpodoxime Proxetil is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Cefpodoxime Proxetil
For more information call (914) 654-6800or email INFO@PARCHEM.COM
(914) 654-6800
INFO@PARCHEM.COM
For more informationemailINFO@PARCHEM.COM
email
INFO@PARCHEM.COM
Product Description
Product
Cefpodoxime Proxetil
CAS
87239-81-4
Formula
C21H27N5O9S2
Synonym
cefpodoxime proxetil, Cefodoxime Proxetil, 87239-81-4, 947692-13-9, (E)-Cefpodoxime Proxetil, anti-Cefpodoxime proxetil, K9VK627SN2, 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, (1RS)-1-(((1-Methylethoxy)carbonyl)oxy)ethyl (6R,7R)-7-(((2E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester, (6R,7R)-, Cefpodoximproxetil, U-76,252;CS-807, UNII-K9VK627SN2, SCHEMBL379709, CHEBI:94455, HMS2093B08, Pharmakon1600-01505637, NSC759161, Cefpodoxime proxetil impurity D [EP], CCG-213498, NCGC00164598-03, SBI-0206821.P001, AB01563099_01, SR-05000001937, Q1052672, SR-05000001937-1, BRD-A87387433-001-01-9, CEFPODOXIME PROXETIL IMPURITY D [EP IMPURITY], L-(-)-Di-1,4-O-benzoyl-L-tartaric acid monohydrate
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Cefpodoxime Proxetil is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
